Teva Pharmaceuticals Europe are pleased to invite you to the European Medical eLearning Program (MeLP) in schizophrenia. 

With a curriculum developed with Prof. Alkomiet Hasan and delivered by leading experts, the programme will offer informative and practical perspectives on the continuing evolution of schizophrenia management. The first two webinars will take place in November and December 2026, with further events throughout 2027.